Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BNT162b2 mRNA COVID-19 Vaccine: First Approval
Yvette N. Lamb
Drugs (2021) Vol. 81, Iss. 4, pp. 495-501
Open Access | Times Cited: 335

Showing 1-25 of 335 citing articles:

Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 401
RNA-based therapeutics: an overview and prospectus
Yiran Zhu, Liyuan Zhu, Xian Wang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 7
Open Access | Times Cited: 353
Nirmatrelvir Plus Ritonavir: First Approval
Yvette N. Lamb
Drugs (2022) Vol. 82, Iss. 5, pp. 585-591
Open Access | Times Cited: 240
Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
Yu‐Chyi Hwang, Ruei‐Min Lu, Shih-Chieh Su, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 198
Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products
Mohamed Yousif Ibrahim, Eslam Ramadan, Nehal E. Elsadek, et al.
Journal of Controlled Release (2022) Vol. 351, pp. 215-230
Open Access | Times Cited: 196
Gene therapy clinical trials, where do we go? An overview
Fatemeh Arabi, Vahid Mansouri, Naser Ahmadbeigi
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113324-113324
Open Access | Times Cited: 157
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
Md. Mijanur Rahman, Md. Habib Ullah Masum, Shah Wajed, et al.
VirusDisease (2022) Vol. 33, Iss. 1, pp. 1-22
Open Access | Times Cited: 98
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 75
Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications
Yoseph Seo, Hayeon Lim, Hyunjun Park, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 772-772
Open Access | Times Cited: 69
Nanovaccines: A game changing approach in the fight against infectious diseases
Priyanka Choudhary, Mai Abdel Haleem Abusalah, Hitesh Chopra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115597-115597
Open Access | Times Cited: 66
Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment
Pablo Graván, Aixa Aguilera-Garrido, Juan Antonio Marchal, et al.
Advances in Colloid and Interface Science (2023) Vol. 314, pp. 102871-102871
Open Access | Times Cited: 59
A Journey of Challenges and Victories: A Bibliometric Worldview of Nanomedicine since the 21st Century
Jingyu Wang, Wenling Zhao, Zhao Zhang, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 36
Chemistry and Art of Developing Lipid Nanoparticles for Biologics Delivery: Focus on Development and Scale-Up
Rijo John, Jasmin monpara, Shankar Swaminathan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 131-131
Open Access | Times Cited: 25
Vaccine Strategies to Elicit Mucosal Immunity
Yufeng Song, Frances Mehl, Steven L. Zeichner
Vaccines (2024) Vol. 12, Iss. 2, pp. 191-191
Open Access | Times Cited: 20
Nanotechnology in healthcare, and its safety and environmental risks
Xiaohan Ma, Yaxin Tian, Yang Ren, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
Javier T. Granados‐Riveron, Guillermo Aquino‐Jarquín
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111953-111953
Open Access | Times Cited: 95
Acceptance of COVID-19 Vaccination among Front-Line Health Care Workers: A Nationwide Survey of Emergency Medical Services Personnel from Germany
André Nohl, Christian Afflerbach, Christian Lurz, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 424-424
Open Access | Times Cited: 58
Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report
Beatriz Endo, Silvana Bahamon, Dayron Fernando Martínez-Pulgarín
Indian Journal of Ophthalmology (2021) Vol. 69, Iss. 10, pp. 2865-2866
Open Access | Times Cited: 56
Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
Zhan Zhang, Qi Shen, Haocai Chang
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 56
The Delivery of mRNA Vaccines for Therapeutics
Nitika Nitika, Wei Jiao, Ai‐Min Hui
Life (2022) Vol. 12, Iss. 8, pp. 1254-1254
Open Access | Times Cited: 50
Current regulatory landscape of nanomaterials and nanomedicines: A global perspective
Faraat Ali, Kumari Neha, Sana Parveen
Journal of Drug Delivery Science and Technology (2022) Vol. 80, pp. 104118-104118
Closed Access | Times Cited: 48
On the size-regulation of RNA-loaded lipid nanoparticles synthesized by microfluidic device
Kento Okuda, Yusuke Sato, Kazuki Iwakawa, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 648-659
Open Access | Times Cited: 47
mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy
Kosuke Sasaki, Yusuke Sato, Kento Okuda, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1572-1572
Open Access | Times Cited: 44
Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection—A comparative study from Novi Sad, Serbia
Vladimir Petrović, Vladimir Vuković, Aleksandra Patić, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263468-e0263468
Open Access | Times Cited: 39
Microfluidic Manufacture of Lipid-Based Nanomedicines
Karim Osouli-Bostanabad, Sara Puliga, Dolores R. Serrano, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1940-1940
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top